Use of convalescent plasma therapy in eight individuals with mild COVID-19

Coronavirus disease 2019 (COVID-19) is still a global epidemic. Several studies of individuals with severe COVID-19 regard convalescent plasma (CP) transfusion as an effective therapy. However, no significant improvements are found in randomized clinical trials of CP treatment. Until now, data for i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, F., Liu, W., Hao, D.-A., Cheng, J., Tong, X.-C., Hao, J.-G., Wang, L.-P., Li, C.-Y., Dai, M.-J., Yan, X.-B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661912/
https://www.ncbi.nlm.nih.gov/pubmed/33204428
http://dx.doi.org/10.1016/j.nmni.2020.100814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661912/
https://www.ncbi.nlm.nih.gov/pubmed/33204428
http://dx.doi.org/10.1016/j.nmni.2020.100814

Ejemplares similares